












































The mammalian cell nucleus is a highly organized and 
dynamic organelle, not simply a house for the genome 
[1]. A number of structures are involved in maintaining 
this high level of organization, among them the nuclear 
lamina, a thin protein layer that separates the nuclear 
envelope from the nuclear interior [2]. The lamina is a 
filamentous meshwork that regulates nuclear structural 
integrity,  the position and size of nuclear pores,  and the  
 
 











































anchorage of heterochromatin at the nuclear periphery. 
It is composed mostly of A- and B-type lamins, a group 
of intermediate filament-like proteins that also reside in 
the internal nuclear matrix. There are 2 A-type lamin 
isoforms, lamin A and C, that originate through 
alternative splicing of the same gene and only differ in 
the carboxy-terminal domain [3]. Lamin A is longer but 
undergoes multistep posttranslational modification 
resulting in cleavage of part of the carboxy-terminal 
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suggesting that the 2 proteins exert redundant functions. 
Perhaps not unexpectedly, the nuclear lamina is a target 
for many human diseases, which are termed generically 
laminopathies [5]. Many of these conditions affect 
lamin A/C but others are caused by mutations in their 
associated proteins (e.g. emerin). In contrast, few 
diseases have been identified so far that are caused by 
mutations in type B-lamins, though this could simply 
reflect that such mutations are embryonic lethal [6]. 
Notably, the clinical variability among lamin A/C-
associated diseases is surprisingly big for a group of 
conditions affecting the same gene. It ranges from 
dilated cardiomyopathy, dermatopathy, osteoskeletal 
dysplasia and lipodistrophy, to more general progeroid 
syndromes including atypical Werner syndrome and 
Hutchinson Gilford progeria. The genotype-phenotype 
correlations are not yet well understood [7] but in all 
cases there is abnormal blebbing of the nuclear 
membrane, which is regarded a hallmark of these 
diseases [8]. Complicating the study of laminopathies, 
over-expression of mutated lamin A variants is 
problematic as it can induce cell senescence [9], and the 
existing animal models do not reproduce the clinical 
complexity observed in humans [10].  
 
The reversion of somatic cell fate to a naïve pluripotent 
state by expressing defined sets of transcription factors is 
a major scientific advance with implications at multiple 
levels [11]. This revolutionary discovery by Takahashi 
and Yamanaka [12] has come in a moment in which there 
is urgent need for novel in vitro molecular biology studies 
that improve our understanding of many human 
conditions, including the laminopathies. iPSC cell lines 
retain the ability to differentiate into specific lineages, 
enabling the study of a given disease in a patient-specific 
and cell-specific context [13]. Many questions remain yet 
unanswered as to how the reprogramming happens and 
whether iPSCs are identical or not to embryonic stem 
cells (ESCs) [14], but these concerns seem less relevant 
for the creation of in vitro disease models. Indeed, a 
series of cell lines have already been established that 
reproduce relevant aspects of the disease phenotype [15-
18], opening a new research era full of possibilities. Our 
study describes an in vitro iPSC-based platform for 
studying the multi-systemic susceptibility to distinct 
mutations in lamin A/C that could be used as well for 




Generation of iPSCs from 3 lamin A/C-associated 
diseases 
 
We  chose  a  patient  with  hereditary  dilated  cardiomyo- 
pathy and conduction system defect, and another one 
with atypical Werner syndrome, hereafter termed DCM 
and aWS respectively. To the best of our knowledge 
these diseases have not been used before for producing 
iPSCs. Cells from a patient with Hutchinson Gilford 
progeria, hereafter termed HGPS, were also 
reprogrammed and used for comparisons. iPSCs from 
patients with HGPS were reported independently by 
Zhang et al. [19] and Liu et al. [20] while our work was 
in preparation, and have proved to be a potentially 
valuable model to understand this disease. DCM 
fibroblasts were obtained by skin biopsy of a 45 years 
old male, who presented with complete atrioventricular 
blockade associated with DCM signs, and contained a 
GCCA insertion at base 50 in the lamin A/C gene 
(Figure 1A and Supplementary Figure). This mutation 
creates a frameshift and premature stop, hence causing 
lamin A/C haploinsufficiency. The echocardiogram 
showed dilated right and left ventricle with left 
ventricular ejection fraction of 48% (data not shown). 
Lamin A/C truncating mutations have been described 
before to produce similar forms of DCM [21,22], but 
this mutation is novel. aWS and HGPS fibroblasts were 
purchased from the Coriell cell repository and contained 
known heterozygous mutations E578V and G608G 
(C1824T, creating an alternatively spliced lamin A 
isoform) respectively in exon 11 of lamin A gene (lamin 
C is not affected) (Figure 1A and Supplementary 
Figure). The latter 2 diseases correspond to accelerated 
forms of aging that affect multiple organs, but the 
clinical presentation is not identical [23,24]. For 
example, HGPS patients develop characteristic 
craniofacial morphology and die at young age of 
vascular complications (myocardial infarction and 
stroke), while aWS patients live longer and are 
phenotypically more variable. aWS is caused by 
mutations thought to alter the interaction of lamin A 
with other proteins, and in HGPS there is over-
production of an abnormally processed form of lamin A, 
termed progerin [25], that has been proposed to interact 
wrongly with nuclear components as well. Lysates from 
fibroblasts of all 3 diseases were analyzed by Western 
blotting and showed reduction of lamin A/C protein in 
DCM, normal levels in aWS, and accumulation of 
progerin in HGPS compared to control fibroblasts 
(Figure 1B). As expected, mRNA levels of lamin A/C 
were comparable to the control in all cases (Figure 1C). 
Immunofluorescence microscopy for lamin A/C 
demonstrated high frequency of nuclear abnormalities 
in the 3 types of affected fibroblasts (Figure 1D-E). This 
was verified by electron microscopy, which also 
detected more subtle differences between them: DCM 
cells contained abundant nuclear pore dilatation, while 
aWS  and HGPS  displayed  frequent thickening  of  the  
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the 3 types of fibroblasts into iPSCs using integrating 





















































(aWS and HGPS).  Colonies resembling human ESCs 
appeared around day 20-25; they were picked around 





















































Figure  1.  iPSCs  from  fibroblasts  with  3
different mutations in lamin A/C. (A) Simplified
scheme  depicting  lamin  A/C  proteins  and  the
corresponding  amino  acid  (AA)  substitutions
(indicated  with  arrows)  in  DCM,  aWS,  and  HGPS
patients.  (B)  Western  blot  showing  reduced
expression  of  lamin  A/C  and  accumulation  of
progerin in primary fibroblasts from DCM and HGPS
patients  respectively.  Normal  human  fibroblasts
were used as control. P indicates passage. Actin was
used as loading control. A representative experiment
is  shown  (this  also  applies  hereafter  when  not
mentioned  otherwise).  (C)  qPCR  analysis  shows
rather  similar  lamin  A/C  expression  in  primary
fibroblasts from the 3 diseases compared to control




bar  indicates  10  μm.  (E)  Quantification  of  cells
displaying abnormal nuclear membrane assessed by
immunofluorescence microscopy and cell counting.
The  mean  of  3  independent  experiments  +/‐
standard  deviation  (SD)  is  shown.  **  indicates  p
value  <0.01  measured  with  Student’s  t‐test.  (F)
Electron  microscopy  photographs  show  nuclear
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iPSCs bearing mutations in lamin A/C are 
pluripotent and display normal nuclear morphology 
 
We characterized selected  iPSC colonies for all 3 
diseases by standard procedures [26]. They stained 
positively for markers such as alkaline phosphatase 
(AP), SSEA-4, TRA-1-60, TRA-1-81, and the 
transcription factor Nanog (Figure 2A). Moreover, they 
displayed normal nuclear morphology as assessed by 
immunofluorescence for the nuclear membrane marker 
LAP2 (Lamina-Associated Polypeptide 2) (Figure 2A). 
This correlated with high expression of ESC-
transcription factors (endogenous Oct4 and Sox2, plus 
Nanog) and hTERT (human telomerase reverse 
transcriptase) comparable to human ESCs and iPSCs 
produced from fibroblasts of a normal individual 
(Figure 2B). However, lamin A/C mRNA levels were 
much lower in all pluripotent cell lines than in control 
fibroblasts (Figure 2C). The latter may explain why 




































also HGPS fibroblasts, could be reprogrammed in spite 
of their slow proliferation and increased senescence 
relative to the donor cells (see below Figure 5). Indeed, 
ESCs are known to have low expression of lamin A/C, 
which increases sharply upon differentiation [27]. 
Besides, others [19]  and we (data not shown) have 
observed reduction of lamin A/C mRNA early after 
transduction with the exogenous factors, likely allowing 
the recovery of normal nuclear morphology after the 
initial phase of reprogramming. The diseased iPSCs also 
displayed normal karyotype (Figure 3A), had low levels 
of CpG methylation in the proximal Oct4 promoter 
(Figure 3B), and produced derivatives of the 3 germ 
layers when growth as teratomas in immuno-
compromised mice (Figure 3C). Therefore, we have 
successfully produced pluripotent cell lines by 
reprogramming of somatic cells from 3 independent 
diseases associated with mutations in lamin A/C 






































karyotype  of  representative  iPSC  clones  from 
patients  with  the  3 diseases.  (B)  DNA  methylation 
profile  of  the  proximal  Oct4  promoter  in  similar 
representative  clones.  Open  circles  indicate 
unmethylated CpGs. The respective donor cells were 
used  as  control.  (C)  Teratomas  produced  from 





















































Acquisition of nuclear abnormalities upon 
differentiation of lamin A/C mutated-iPSCs 
 
To evaluate the potential of our iPSC cell lines for 
understanding the complexity of the 3 laminopathies, 


















































acquisition of mesenchymal-like characteristics in the 
iPSC-derived fibroblasts was validated by immuno-
fluorescence microscopy for actin stress fibers, the 
intermediate filament vimentin and the extracellular 
matrix protein fibronectin. All secondary fibroblasts, 
including those from a non-affected iPSC clone, display- 
Figure 4. Nuclear abnormalities are restored in iPSC‐derived fibroblasts containing mutations in
























































































































Figure  5.  Increased  senescence  and  susceptibility  to  apoptosis  in  iPSC‐derived  fibroblasts
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blotting verified the up-regulation of lamin A/C 
compared to iPSCs (Figure 4B), and the acquisition of 
nuclear blebbing was demonstrated by immuno-
fluorescence (Figure 4A and C) and electron 
microscopy (Figure 4D). Notably, the latter technique 
reproduced the more subtle differences in pore size and 
membrane thickening observed with the primary cells. 
Then we analyzed whether these changes were 
associated with cell senescence (Figure 5A-C) and slow 
proliferation (Figure 5D-E), as observed with the 
respective primary fibroblasts. Both parameters were 
significantly increased in secondary fibroblasts from the 
3 diseases, though the tendency to display a more 
marked phenotype in HGPS was less obvious than in 
primary cells. This is probably related to the earlier 
onset of disease in HGPS patients and the moment in 
which the primary cells were collected. Likewise, we 
exposed primary and secondary fibroblasts to electrical 
stimulation because this physical stress has been shown 
to increase nuclear blebbing and apoptosis in vascular 
smooth muscle cells derived from HGPS iPSCs [19]. 
Primary and secondary fibroblasts displayed higher 
basal apoptosis compared to controls and there was 
synergistic increase upon electrical stimulation without 
significant bias among the 3 laminophaties (Figure 5F-
G). Other stresses like hypoxia or gamma irradiation 
showed no noticeable difference between normal and 
diseased secondary fibroblasts (data not shown). In 
addition, we did not detect differential apoptosis after 
electrical stimulation between normal and affected 
iPSCs (data not shown), in agreement with their low 
levels of lamin A/C. Hence, reprogramming of somatic 
cells with mutations in lamin A/C reverses their 
abnormal phenotype thanks to reduction in protein 
expression, but differentiation back into the original 




We aimed to create a panel of iPSC cell lines containing 
distinct mutations in lamin A/C, as this could be used to 
study genotype-phenotype correlation in the respective 
diseases. DCM is produced by lamin A/C 
haploinsufficiency and displays a very restricted heart 
phenotype. As for the progerias, this term comprises 
several unrelated conditions in which some aspects of 
normal aging seem accelerated, but not all of them are 
laminopathies [28,29]. HGPS is termed progeria of the 
infancy because the clinical phenotype starts 
manifesting after the first years of life, while aWS 
clinically resembles another condition -the classical 
Werner syndrome- produced by mutations in the WRN 
gene [30] and causes progressive degeneration during 
adulthood. In both aWS and HGPS the abnormalities 
are systemic, though some tissues seem more 
susceptible. For the in vitro disease modeling using 
iPSCs we chose secondary fibroblasts because they are 
a clinically relevant cell type in many contexts and a 
well-established cell model for studying laminopathies. 
They reproduced the alterations of the nuclear 
membrane, slow proliferation, senescence, and 
susceptibility to apoptosis of the primary cell lines, 
supporting the idea that conversion to pluripotency does 
not affect their ability to degenerate upon 
differentiation. This similarity between 3 diseases that 
have different clinical manifestations is nevertheless 
puzzling. Fibroblasts likely do not cause the heart 
phenotype in DCM, as like in related cases the basis lies 
mainly in the conduction system, though we cannot 
formally exclude some contribution. On the other hand, 
DCM patients do not bear noticeable skin or 
osteoskeletal abnormalities, that are caused at least in 
part by fibroblasts, but this is a hallmark of the 2 
progerias and in particular HGPS [31]. As for the 
appearance of heart disease in the progerias, aWS 
patients can actually acquire changes comparable to 
DCM, but HGPS patients die before these signs can 
develop. Therefore, it is plausible to argue that the 
analogous nuclear membrane and senescent/apoptotic 
changes observed in vitro for primary and secondary 
cells of the 3 laminopathies are a magnification caused 
by the tissue culture. In this regard, fibroblasts become 
senescent quicker outside the body context due to 
mitochondrial respiration and accumulation of free 
radical species [32]. This could imply that in vivo the 
defect of aWS, and in particular HGPS, is qualitatively 
similar but quantitatively stronger compared to DCM. 
This would explain that in DCM only those cells 
exposed to more substantial and continuous physical 
stress (like cardiomyocytes) develop the disease and 
with late onset, while in the progerias the defects are 
systemic and/or appear earlier. Even if this hypothesis 
were true, a different question is how functionally 
different mutations in lamin A/C can trigger the same 
molecular consequence. Insufficient levels of lamin A/C 
unavoidably cause the abnormal phenotype in DCM 
cells. Then, one would expect that mutant lamin A in 
aWS and HGPS should cause the same changes through 
a loss of function. But this is counterintuitive and 
against the current dogma, as in particular progerin is 
believed to act through gain of function. Besides, even 
though lamin A is affected in the 2 progerias, lamin C is 
not, and thanks to functional overlap one protein should 
be able to substitute the other. An alternative scenario 
would be that the uneven nuclear morphology and 
susceptibility to stress commonly used as readout for 
the laminopathies are to some extent misleading (at 
least for aWS and HGPS) and underscore different more 
relevant alterations. In this regard, our electron 
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between primary and secondary fibroblasts for the 3 
conditions. It is possible that nuclear pore changes in 
DCM only moderately influence trafficking in and out 
of this compartment but the added continuous stretching 
of cardiomyocytes progressively enlarges the defect and 
generates other abnormalities as well. On the other side, 
nuclear lamina thickening has been described before for 
HGPS primary fibroblasts and proposed to alter the 
anchorage of heterochromatin at the nuclear periphery 
[33]. This phenomenon could potentially influence the 
balance between activating and repressive transcript-
tional complexes in certain areas of the genome and 
thus change the epigenome [34,35]. Yet, why specific 
cell types (e.g. vascular smooth muscle cells and 
mesenchymal stem cells) seem more prone to changes 
in vivo for example in HGPS is still unclear [19]. 
Smooth muscle cells in the aorta are steadily exposed to 
stretching due to high pressure and shear stress 
produced by blood flow. It is thus possible that the 
stress in this location enhances existing epigenetic 
changes or combines with them. On the other hand, 
mesenchymal stem cells reside in parts of the anatomy 
where oxygen concentration is low and need to travel 
long distances before they can contribute to tissue repair 
and homeostasis [36]. Besides, upon arrival to a given 
tissue they undergo profound epigenetic transformations 
in order to acquire different cell fates, and the thickened 
lamina may restrict this ability. In summary, although we 
cannot answer yet many of these questions, our panel of 
cell lines and those generated elsewhere [19,20] provide 
a state of the art methodology to investigate them. In the 
future, the application of proteomic, metabolomic, or 
genomic approaches to a more varied differentiated 
progeny originated from these iPSCs may contribute to 
change our understanding of a group of diseases for 
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Cell culture and iPSC generation. AWS (AG04110) and 
HGPS (AG06917) fibroblasts were purchased from the 
Coriell cell repository. The mutations in all primary 
cells and/or the resulting iPSCs were verified by 
sequencing (Supplementary Figure). All fibroblasts 
were maintained in DMEM (Invitrogen) + 10% fetal 
bovine serum (FBS) (Hyclone). Fibroblasts at passage 2 
(DCM), 9 (aWS) and 17 (HGPS) were transduced with 
a cocktail of retroviruses (producing Sox2, Klf4, Oct4 
and c-Myc) or lentiviruses (Sox2, Klf4, Oct4, c-Myc, 
Lin28 and Nanog) as reported before [26,37,38]. 
Fibroblasts from a normal individual were 
reprogrammed with the above lentiviruses and the 
primary cells and/or iPSCs were used as controls where 
indicated. Picked iPSCs and human ESCs were 
routinely maintained on feeders (mitotically inactivated-
murine embryonic fibroblasts) in human ESC medium 
(DMEM/F12 plus 20% KnockOut serum replacement 
(KSR, Invitrogen), penicillin/streptomycin, 1 mM 
Glutamine, 0.1 mM non-essential amino acids, 0.1 mM 
beta-mercaptoethanol and 8 ng/ml bFGF (Shenzhen 
Symmix Industry) or on Matrigel (BD Biosciences) in 
mTeSR1 (Stemcell Technologies).  
 
iPSC characterization.  AP staining, transgene 
integration, karyotyping and bisulfate sequencing were 
performed following standard procedure. For aWS and 
HGPS we also performed single tandem repeat analysis 
(Kingmed) to show a match between donor cells and 
iPSCs (data not shown). Genomic DNA was extracted 
using the DNeasy Tissue kit (Qiagen) and total RNA 
was extracted using Trizol (Invitrogen). qPCR was 
performed using a Thermal Cycler DiceTM Real Time 
System (ABI7300, ABI) and SYBR Green Premix EX 
TaqTM (Takara); beta actin or GAPDH were used for 
normalization and all items were measured in triplicate 
(SD is included in some graphs). qPCR primers used in 
this study are available upon request. Secondary 
fibroblast differentiation was done following a reported 
protocol [39]. For teratomas, iPSCs were injected 
subcutaneously or intramuscularly into the right hind 
leg of immuno-compromised NOD-SCID mice. Tumors 
were excised after 8 weeks, fixed, embedded in paraffin, 
sectioned and stained with hematoxylin/eosin. 
 
Immunofluorescence microscopy, electron microscopy 
and Western blotting. For immunofluorecence, cells 
were fixed in 4% paraformaldehyde for 30 minutes, 
washed, blocked and permeabilized in blocking solution 
(PBS containing 3% normal goat serum and 0.2% 
Triton X-100) for 30 minutes. Then they were incubated 
with primary antibodies in blocking solution at 4°C 
overnight, washed twice and incubated with the 
corresponding secondary antibodies for 1 hour at room 
temperature. Cells were washed twice and stained with 
DAPI (Sigma) for 5 minutes, and then observed and 
photographed using a LEICA DMI6000B microscope 
(Leica Microsystems GmbH). For quantification of 
nuclear abnormalities ten fields were counted per slide 
and 3 slides were counted per experiment.  For electron 
microscopy primary and secondary fibroblasts were 
harvested and washed in PBS. The cell pellets were 
fixed in 2% paraformaldehyde and 1% glutaraldehyde 
   
www.impactaging.com                     388                                         AGING, April 2011, Vol.3   No.4in 0.1 M sodium cacodylate-HCl buffer pH 7.4. Next, 
they were then stained with 1% osmium tetroxide 
(OsO4) in cacodylate buffer for 1 hour at room 
temperature and washed twice in 0.1 M sodium 
cacodylate-HCl buffer. The cells were then embedded in 
2% agarose, dehydrated and embedded in epoxy resin. 
Ultrathin sections were examined by transmission 
electron microscopy using a Philips EM208s 
microscope. Western blot membranes were developed 
using Immobilon Western Chemiluminescent HRP 
Substrate (Millipore). Primary antibodies were 
purchased from: lamin A/C Santa Cruz, LAP2 BD 
Biosciences, fibronectin and vimentin Sigma, Nanog 
R&D, SSEA-4 Abcam, TRA-1-60 and TRA-1-81 
Millipore. 
 
β–galactosidase/Annexin V assays, proliferation and 
electrical stimulation.  β-galactosidase detection was 
performed using a kit (Cell Signalling Technology Inc) 
according to the manufacturer’s instructions. Senescent 
cells were indicated by the development of blue color 
under the microscope at 200x. Blue cells in 20 random 
fields were counted in duplicate wells of each 
experiment. Annexin V apoptotic assay was performed 
using a kit according to manufacturer’s instruction (BD 
Biosciences). The percentage of apoptotic cells was 
measured by flow cytometry (Beckman Coulter) and 
10,000 events were counted. Proliferation was measured 
using the MTT assay, samples were measured in 
triplicate. For electrical stimulation primary and 
secondary fibroblasts were seeded at 1x10
5 cells per 
well (in triplicate) on 6-wells plates (Nunc A/S) and 
subjected to electric field stimulation with an eight-
channel C-Pace chronic stimulator (Ion-Optics Co., 
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